PAVmed Inc. financial data

Symbol
PAVM, PAVMZ on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
360 Madison Avenue, 25 Th Floor, New York, NY
State of incorporation
DE
Fiscal year end
December 31
Former names
PAXmed Inc. (to 3/26/2015)
Latest financial report
10-K - Q4 2024 - Mar 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 35.3 % -51.8%
Quick Ratio 0.69 %
Debt-to-equity -129 % +13.3%
Return On Equity -286 % -133%
Return On Assets 115 %
Operating Margin -1.48K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 16.8M shares +80.1%
Common Stock, Shares, Outstanding 11.2M shares +30.5%
Entity Public Float 7M USD -81.9%
Common Stock, Value, Issued 11K USD +22.2%
Weighted Average Number of Shares Outstanding, Basic 9.67M shares +33.8%
Weighted Average Number of Shares Outstanding, Diluted 65.3M shares +803%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 3M USD
Revenue from Contract with Customer, Excluding Assessed Tax 3M USD +22.1%
Cost of Revenue 4.84M USD -24.6%
Research and Development Expense 5.93M USD -58.4%
Selling and Marketing Expense 11.6M USD -33.9%
General and Administrative Expense 24.5M USD -20.8%
Costs and Expenses 47.5M USD -33.4%
Operating Income (Loss) -44.5M USD +35.3%
Nonoperating Income (Expense) 72.9M USD
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 28.4M USD
Net Income (Loss) Attributable to Parent 39.8M USD
Earnings Per Share, Basic 6.43 USD/shares
Earnings Per Share, Diluted 0.5 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 1.19M USD -94%
Accounts Receivable, after Allowance for Credit Loss, Current 18K USD -70.5%
Inventory, Net 6K USD
Assets, Current 2.16M USD -91.2%
Property, Plant and Equipment, Net 151K USD -91.5%
Operating Lease, Right-of-Use Asset 2.5M USD -41.4%
Intangible Assets, Net (Excluding Goodwill) 947K USD -61.1%
Other Assets, Noncurrent 208K USD -81.9%
Assets 30.7M USD -7.43%
Accounts Payable, Current 657K USD -63.2%
Employee-related Liabilities, Current 1.15M USD -54.1%
Accrued Liabilities, Current 5.18M USD -21.9%
Liabilities, Current 35.4M USD -34.6%
Operating Lease, Liability, Noncurrent 2.25M USD -24.1%
Liabilities 37.7M USD -34%
Retained Earnings (Accumulated Deficit) -255M USD +13.4%
Stockholders' Equity Attributable to Parent -2.5M USD +95.4%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest -7.03M USD +70.7%
Liabilities and Equity 30.7M USD -7.43%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -13.1M USD +19.9%
Net Cash Provided by (Used in) Financing Activities 19M USD -23.6%
Net Cash Provided by (Used in) Investing Activities -42K USD -104%
Common Stock, Shares Authorized 250M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.9M USD -38.2%
Deferred Tax Assets, Valuation Allowance 42M USD -55.1%
Deferred Tax Assets, Gross 42.9M USD -54.8%
Operating Lease, Liability 2.76M USD -39%
Payments to Acquire Property, Plant, and Equipment 42K USD +61.5%
Lessee, Operating Lease, Liability, to be Paid 3.35M USD -38.2%
Property, Plant and Equipment, Gross 1.4M USD -59.9%
Operating Lease, Liability, Current 513K USD -67.2%
Lessee, Operating Lease, Liability, to be Paid, Year Two 724K USD -13.3%
Lessee, Operating Lease, Liability, to be Paid, Year One 708K USD -61.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 585K USD -34%
Lessee, Operating Lease, Liability, to be Paid, Year Three 594K USD -24.5%
Deferred Tax Assets, Operating Loss Carryforwards 30.4M USD -55.1%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 471K USD -23.7%
Operating Lease, Payments 476K USD +37.6%
Additional Paid in Capital 249M USD +4.86%
Amortization of Intangible Assets 559K USD -72.3%
Depreciation, Depletion and Amortization 586K USD -19.4%
Deferred Tax Assets, Net of Valuation Allowance 51.6M USD
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%